Peter Leutscher

Peter Leutscher

Auto-generated profile, based on publicly available information

Peter Leutscher

Center for Clinical Research, North Denmark Regional Hospital, Hjørring, Denmark

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Trends in Parasitology
Verified
Journal Article
Closed access
EKEyrun Kjetland
Eyrun Kjetland
PLPeter D.C. Leutscher
Peter D.C. Leutscher
PNPatricia D. Ndhlovu
Patricia D. Ndhlovu

24 April 2020 in Gut Microbes
Verified
Journal Article
Open access
CBCaspar Bundgaard-Nielsen
Caspar Bundgaard-Nielsen
JKJulie Knudsen
Julie Knudsen
PLPeter D. C. Leutscher
Peter D. C. Leutscher
MLMarlene B. Lauritsen
Marlene B. Lauritsen
MNMette Nyegaard
Mette Nyegaard
SSSuzette Sørensen
Suzette Sørensen
Accumulating evidence has implicated an involvement of the gut-brain axis in autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD), however with highly diverse results. This systematic review aims to describe and evaluate studies investigating the gut microbiota composition in individuals with ASD or ADHD and to evaluate if variations in gut microbiota are associated with these disorders. Twenty-four articles were identified in a systematic literature search of PubMed and Embase up to July 22, 2019. They consisted of 20 studies investigating ASD and four studies investigating ADHD. For ASD, several studies agreed on an overall difference in β-diversity, although no consistent bacterial variation between all studies was reported. For ADHD, the results were more diverse, with no clear differences observed. Several common characteristics in gut microbiota function were identified for ASD compared to controls. In contrast, highly heterogeneous results were reported for ADHD, and thus the association between gut microbiota composition and ADHD remains unclear. For both disorders, methodological differences hampered the comparison of studies.

1 April 1998 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
PLP. Leutscher
P. Leutscher
VRV. E. Ravaoalimalala
V. E. Ravaoalimalala
CRC. Raharisolo
C. Raharisolo
CRC. E. Ramarokoto
C. E. Ramarokoto
MRM. Rasendramino
M. Rasendramino
HFH. Feldmeier
H. Feldmeier
To assess the morbidity of S. haematobium infection in women of reproductive age (15–49 years) in the western part of Madagascar, the village of Betalatala with a prevalence of urinary schistosomiasis in women of 75.6% (95% confidence limit 69.3 to 81.9%) was compared with a neighbouring village with similar socio‐economic characteristics and a prevalence of 5.0% (95% confidence limit 0 to 11.75%). The women were questioned in Malagasy about obstetrical history and urogynecological symptoms. They were examined gynaecologically, parasitologically and by ultrasonography. Important STDs were excluded by appropiate diagnostics. In Betalatala significantly more women reported a history of spontaneous abortion (P < 0.01), complaints of irregular menstruation (P < 0.001), pelvic pain (<0.05), vaginal discharge (P < 0.0001), dysuria (P < 0.05) and haematuria (P < 0.01) than in the control village. Biopsies were obtained from the cervix of 36 women with macroscopical lesions, and in 12 cases S. haematobium eggs were found by histological sectioning (33.3%). In the control village no eggs were detected in the histological sections of biopsies taken from 14 women. (P < 0.05). Infections with Candida albicans, Trichomonas vaginalis, Gardnerella vaginalis and Treponema pallidum were found in similar frequencies in both villages. In 9.8% of the women in Betalatala abnormalities of the upper reproductive tract were revealed by ultrasonography versus none in the women from the control village (P < 0.05). Echographic abnormalities of the urinary tract were present in 24% and 3% of the women in the study village and in the control village, respectively (P < 0.0001). These findings were accompanied by an elevated frequency of haematuria (55% versus 20%) and proteinuria (70.4% versus 25%) in the study population (P < 0.0001). Our study indicates that S. haematobium infection in women may not only cause symptoms in the urinary tract, but also frequently in the lower and upper reproductive tract.

1 January 2000 in The Lancet
Verified
Journal Article
Closed access
PLPeter Leutscher
Peter Leutscher
CRCharles-Emile Ramarokoto
Charles-Emile Ramarokoto
CRClaus Reimert
Claus Reimert
HFHermann Feldmeier
Hermann Feldmeier
PEPhilippe Esterre
Philippe Esterre
BVBirgitte J Vennervald
Birgitte J Vennervald

15 May 2005 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
PLPeter D. C. Leutscher
Peter D. C. Leutscher
MPMette Pedersen
Mette Pedersen
CRClairette Raharisolo
Clairette Raharisolo
JJJørgen Skov Jensen
Jørgen Skov Jensen
SHSteen Hoffmann
Steen Hoffmann
HUHenrik Ullum
Henrik Ullum
In this study, we investigated the seminal inflammatory response to egg infestation of the urogenital organs in 240 semen-donating men aged 15–49 yea

23 July 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
PLPeter Derek Christian Leutscher
Peter Derek Christian Leutscher
MLMartin Lagging
Martin Lagging
MBMads Rauning Buhl
Mads Rauning Buhl
CPCourt Pedersen
Court Pedersen
GNGunnar Norkrans
Gunnar Norkrans
FGfor the NORDynamIC Group
for the NORDynamIC Group
The Major Depression Inventory (MDI) was used to estimate the value of routine medical interviews in diagnosing major depression among patients receiving peginterferon alfa-2a and ribavirin therapy for chronic hepatitis C virus (HCV) infection (n = 325). According to criteria from the MDI and Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 19 patients (6%) had major depression at baseline. An additional 114 (37%) developed depression while on HCV combination therapy, with baseline MDI score and female sex independently predicting the emergence of major depression during treatment in a multivariate analysis. Only 36 (32%) of the 114 patients developing major depression according to MDI/DSM-IV criteria were correctly diagnosed during routine medical interviews. The emergence of major depression frequently led to premature discontinuation of peginterferon/ribavirin therapy, and an on-treatment MDI score increment exceeding 30 points (i.e., a validated marker of idiopathic DSM-IV major depression) was correlated with impaired outcome of HCV therapy (P = 0.02). This difference was even more pronounced among patients with an on-treatment increase in MDI score greater than 35 points (P = 0.003). Conclusion: We conclude that (1) depressive symptoms among patients undergoing HCV therapy are commonly overlooked by routine clinical interviews, (2) the emergence of depression compromises the outcome of HCV therapy, and (3) the MDI scale may be useful in identifying patients at risk for treatment-induced depression. (HEPATOLOGY 2010;)